Target Cancer - After Long Fight, Melanoma Drug Gives Sudden Reprieve - Series - NYTime... - 1 views
-
For the melanoma patients who signed on to try a drug known as PLX4032, the clinical trial was a last resort. Their bodies were riddled with tumors, leaving them almost certainly just months to live.
-
But a few weeks after taking their first dose, nearly all of them began to recover.
